NASDAQ:VCNX - Vaccinex News Headlines

$4.99
+0.10 (+2.04 %)
(As of 08/18/2019 02:57 PM ET)
Today's Range
$4.63
Now: $4.99
$4.99
50-Day Range
$4.05
MA: $4.71
$5.52
52-Week Range
$3.32
Now: $4.99
$11.63
Volume1,800 shs
Average Volume6,206 shs
Market Capitalization$74.15 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Vaccinex (NASDAQ VCNX) News Headlines

Source:
DateHeadline
Vaccinex (NASDAQ:VCNX) Issues Quarterly  Earnings ResultsVaccinex (NASDAQ:VCNX) Issues Quarterly Earnings Results
www.americanbankingnews.com - August 15 at 11:20 AM
Vaccinex Reports Second Quarter 2019 Financial Results and Provides Corporate UpdateVaccinex Reports Second Quarter 2019 Financial Results and Provides Corporate Update
finance.yahoo.com - August 14 at 11:11 AM
Vaccinex Announces Full Enrollment Achieved in Ongoing CLASSICAL-Lung Phase 1b/2 Trial of PepinemabVaccinex Announces Full Enrollment Achieved in Ongoing CLASSICAL-Lung Phase 1b/2 Trial of Pepinemab
www.nasdaq.com - August 13 at 11:17 AM
Vaccinex achieves enrollment target in pepinemab lung cancer studyVaccinex achieves enrollment target in pepinemab lung cancer study
seekingalpha.com - August 13 at 11:17 AM
Vaccinex Announces Full Enrollment Achieved in Ongoing CLASSICAL-Lung Phase 1b/2 Trial of Pepinemab in Combination with BAVENCIO® (avelumab) in Advanced Non-Small Cell Lung CancerVaccinex Announces Full Enrollment Achieved in Ongoing CLASSICAL-Lung Phase 1b/2 Trial of Pepinemab in Combination with BAVENCIO® (avelumab) in Advanced Non-Small Cell Lung Cancer
finance.yahoo.com - August 13 at 11:17 AM
Vaccinex Inc (NASDAQ:VCNX) Short Interest UpdateVaccinex Inc (NASDAQ:VCNX) Short Interest Update
www.americanbankingnews.com - August 13 at 4:44 AM
Insiders Roundup: Bezos Sells AmazonInsiders Roundup: Bezos Sells Amazon
finance.yahoo.com - August 2 at 3:55 PM
Vaccinex Inc (NASDAQ:VCNX) Insider Maurice Zauderer Acquires 183,824 SharesVaccinex Inc (NASDAQ:VCNX) Insider Maurice Zauderer Acquires 183,824 Shares
www.americanbankingnews.com - July 31 at 5:35 PM
Insider Buying: Vaccinex Inc (NASDAQ:VCNX) Director Acquires 1,838,235 Shares of StockInsider Buying: Vaccinex Inc (NASDAQ:VCNX) Director Acquires 1,838,235 Shares of Stock
www.americanbankingnews.com - July 31 at 5:33 PM
Vaccinex down 9% on capital raiseVaccinex down 9% on capital raise
seekingalpha.com - July 31 at 1:21 PM
 Analysts Expect Vaccinex Inc (NASDAQ:VCNX) to Post -$0.70 Earnings Per Share Analysts Expect Vaccinex Inc (NASDAQ:VCNX) to Post -$0.70 Earnings Per Share
www.americanbankingnews.com - July 28 at 8:21 PM
Vaccinex Inc (NASDAQ:VCNX) Sees Significant Increase in Short InterestVaccinex Inc (NASDAQ:VCNX) Sees Significant Increase in Short Interest
www.americanbankingnews.com - July 26 at 9:38 PM
Vaccinex Presents Updated Interim Results from a Phase 1b/2 Study of Pepinemab in Combination with Avelumab in Non-Small Cell Lung Cancer at the 2019 ASCO Annual MeetingVaccinex Presents Updated Interim Results from a Phase 1b/2 Study of Pepinemab in Combination with Avelumab in Non-Small Cell Lung Cancer at the 2019 ASCO Annual Meeting
finance.yahoo.com - June 3 at 11:36 AM
Vaccinex Announces Poster Presentations at the 2019 ASCO Annual MeetingVaccinex Announces Poster Presentations at the 2019 ASCO Annual Meeting
finance.yahoo.com - May 27 at 11:17 AM
Vaccinex Reports First Quarter 2019 Financial Results and Provides Corporate UpdateVaccinex Reports First Quarter 2019 Financial Results and Provides Corporate Update
www.nasdaq.com - May 15 at 11:51 AM
Vaccinex, Inc. Summary of Key Data Presented at the 2019 Annual Meeting of the American Association for Cancer Research (AACR)Vaccinex, Inc. Summary of Key Data Presented at the 2019 Annual Meeting of the American Association for Cancer Research (AACR)
finance.yahoo.com - April 9 at 1:34 PM
Vaccinex up 26% on AACR presentationsVaccinex up 26% on AACR presentations
seekingalpha.com - April 1 at 3:53 PM
Vaccinex, Inc. to Provide Clinical Data on Posters Presented at the 2019 Annual Meeting of the American Association for Cancer Research (AACR)Vaccinex, Inc. to Provide Clinical Data on Posters Presented at the 2019 Annual Meeting of the American Association for Cancer Research (AACR)
finance.yahoo.com - April 1 at 12:46 PM
Vaccinex Reports Fourth Quarter 2018 Financial Results and Provides Corporate UpdateVaccinex Reports Fourth Quarter 2018 Financial Results and Provides Corporate Update
finance.yahoo.com - March 13 at 10:16 AM
Vaccinex, Inc. to Present at the Oppenheimer & Co. 29th Annual Healthcare Conference on March 19, 2019Vaccinex, Inc. to Present at the Oppenheimer & Co. 29th Annual Healthcare Conference on March 19, 2019
finance.yahoo.com - March 13 at 10:16 AM
Vaccinex, Inc. to Present Data on Its Anti-SEMA4D Compound at the American Association for Cancer Research Annual Meeting 2019Vaccinex, Inc. to Present Data on Its Anti-SEMA4D Compound at the American Association for Cancer Research Annual Meeting 2019
finance.yahoo.com - March 6 at 11:55 AM
Vaccinex, Inc. Presented Previously Disclosed Data from Ongoing Phase 1/2 Trial of VX15/2503 (Pepinemab) in Huntington’s Disease (the “SIGNAL Trial”) at Cambridge Healthtech Institute’s 18th Annual PepTalkVaccinex, Inc. Presented Previously Disclosed Data from Ongoing Phase 1/2 Trial of VX15/2503 (Pepinemab) in Huntington’s Disease (the “SIGNAL Trial”) at Cambridge Healthtech Institute’s 18th Annual PepTalk
finance.yahoo.com - January 17 at 11:56 AM
Vaccinex Inc.Vaccinex Inc.
www.barrons.com - January 16 at 3:32 PM
Vaccinex, Inc. Announces Completion of Enrollment for Its “SIGNAL” Huntington’s Disease TrialVaccinex, Inc. Announces Completion of Enrollment for Its “SIGNAL” Huntington’s Disease Trial
finance.yahoo.com - January 16 at 10:31 AM
Do Insiders Own Lots Of Shares In Vaccinex, Inc. (NASDAQ:VCNX)?Do Insiders Own Lots Of Shares In Vaccinex, Inc. (NASDAQ:VCNX)?
finance.yahoo.com - December 12 at 3:24 PM
Preclinical Data on Vaccinex, Inc. Anti-SEMA4D Monoclonal Antibody in Combination with Checkpoint Inhibitors Published in Cancer Immunology ResearchPreclinical Data on Vaccinex, Inc. Anti-SEMA4D Monoclonal Antibody in Combination with Checkpoint Inhibitors Published in Cancer Immunology Research
finance.yahoo.com - December 12 at 9:22 AM
Vaccinex, Inc. to Present at the 11th Annual LD Micro Main EventVaccinex, Inc. to Present at the 11th Annual LD Micro Main Event
finance.yahoo.com - November 27 at 3:22 PM
Vaccinex, Inc. Gives Podium Presentation and Poster at the Society for Immunotherapy of Cancer Annual MeetingVaccinex, Inc. Gives Podium Presentation and Poster at the Society for Immunotherapy of Cancer Annual Meeting
finance.yahoo.com - November 15 at 3:20 PM
Vaccinex Inc (VCNX.OQ)Vaccinex Inc (VCNX.OQ)
www.reuters.com - November 13 at 3:22 PM
Vaccinex Reports Third Quarter 2018 Financial Results and Provides Corporate UpdateVaccinex Reports Third Quarter 2018 Financial Results and Provides Corporate Update
finance.yahoo.com - November 13 at 3:22 PM
Vaccinex, Inc. Presents Overview of the Clinical Development of VX15 (pepinemab) for the Potential Treatment of Huntington’s Disease at the Huntington Study Group’s 2018 Annual MeetingVaccinex, Inc. Presents Overview of the Clinical Development of VX15 (pepinemab) for the Potential Treatment of Huntington’s Disease at the Huntington Study Group’s 2018 Annual Meeting
finance.yahoo.com - November 12 at 3:20 PM
Vaccinex, Inc. to Present Data on Its Semaphorin 4D Monoclonal Antibody Programs at Two Conferences Focused on Cancer Immunotherapy and Huntington’s DiseaseVaccinex, Inc. to Present Data on Its Semaphorin 4D Monoclonal Antibody Programs at Two Conferences Focused on Cancer Immunotherapy and Huntington’s Disease
finance.yahoo.com - November 6 at 3:20 PM
Vaccinex, Inc. to Participate on a Panel and Meet with Investors at the BTIG Healthcare Conference October 25, 2018Vaccinex, Inc. to Participate on a Panel and Meet with Investors at the BTIG Healthcare Conference October 25, 2018
finance.yahoo.com - October 23 at 3:18 PM
Vaccinex (VCNX) Presents Prelim. Data on Its Anti-Semaphorin 4D Monocolonal Antibody TechnologyVaccinex (VCNX) Presents Prelim. Data on Its Anti-Semaphorin 4D Monocolonal Antibody Technology
www.streetinsider.com - October 3 at 3:17 PM
Vaccinex, Inc. Presents Preliminary Data on Its Anti-Semaphorin 4D Monocolonal Antibody Technology at the Fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy ConferenceVaccinex, Inc. Presents Preliminary Data on Its Anti-Semaphorin 4D Monocolonal Antibody Technology at the Fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference
finance.yahoo.com - October 2 at 3:17 PM
Vaccinex, Inc. to Participate in Podium and Poster Sessions at the Fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy ConferenceVaccinex, Inc. to Participate in Podium and Poster Sessions at the Fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference
finance.yahoo.com - September 27 at 3:17 PM
Vaccinex, Inc. to Present at the Ladenburg Thalmann 2018 Healthcare ConferenceVaccinex, Inc. to Present at the Ladenburg Thalmann 2018 Healthcare Conference
finance.yahoo.com - September 25 at 3:17 PM
Why Did Vaccinex Inc’s’ (NASDAQ:VCNX) Insiders Buy Up More Shares?Why Did Vaccinex Inc’s’ (NASDAQ:VCNX) Insiders Buy Up More Shares?
finance.yahoo.com - September 13 at 3:16 PM
Oppenheimer: Vaccinex Has Catalysts In Novel Therapies For Challenging DiseasesOppenheimer: Vaccinex Has Catalysts In Novel Therapies For Challenging Diseases
finance.yahoo.com - September 4 at 3:16 PM
Stocks To Watch: Time To Talk ValuationStocks To Watch: Time To Talk Valuation
seekingalpha.com - September 1 at 3:15 PM
US IPO Week Ahead: The calm before the FallUS IPO Week Ahead: The calm before the Fall
www.nasdaq.com - September 1 at 5:33 AM
The IPO Outlook For The Week: An Airline, A Biotech And 2 BanksThe IPO Outlook For The Week: An Airline, A Biotech And 2 Banks
finance.yahoo.com - August 17 at 2:45 PM
Vaccinex Announces Pricing of Initial Public OfferingVaccinex Announces Pricing of Initial Public Offering
finance.yahoo.com - August 17 at 2:45 PM
Vaccinex prices IPO at $12, low end of price rangeVaccinex prices IPO at $12, low end of price range
finance.yahoo.com - August 17 at 2:45 PM
Vaccinex shares slide 3% on their first day of tradeVaccinex shares slide 3% on their first day of trade
finance.yahoo.com - August 17 at 2:45 PM
This page was last updated on 8/18/2019 by MarketBeat.com Staff

Featured Article: Quantitative Easing

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel